ONC releases wave five of 2014 draft test procedures

Editorial Staff | | Health Exec | Policy & Regulations

The Office of the National Coordinator for Health IT (ONC) published wave five of the draft test procedures for the 2014 edition of EHR certification criteria and is inviting the public to comment.

The procedures, which are intended to be finalized and published by early 2013, will be used by testing laboratories and certification bodies authorized by the ONC HIT Program to determine EHR systems’ compliance with standards established by the Department of Health and Human Services.

The public comment period for wave five draft test procedures will last for the two weeks following their publication date, Oct. 18. Specific criterion are listed on the ONC website and include:

  • Transitions of care;
  • Electronic prescribing;
  • View, download and transmit to third party; and
  • Inpatient setting transmission of reportable laboratory results.

Editorial Staff

Related Content

Report: UnitedHealth under investigation by DOJ for Medicare Advantage upcoding
FDA approves first therapy for very rare lipid storage disorder
FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary
FDA ends semaglutide shortage, closing the door on compounded Wegovy, Ozempic
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues
Federal judge sides with FTC; case against PBMs to move forward

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”